Fram D B, Mitchel J F, Azrin M A, Chow M S, Waters D D, McKay R G
Department of Internal Medicine, Hartford Hospital, University of Connecticut 06102, USA.
Cathet Cardiovasc Diagn. 1997 Jul;41(3):275-86. doi: 10.1002/(sici)1097-0304(199707)41:3<275::aid-ccd8>3.0.co;2-3.
The purpose of this study was to assess the efficacy of local heparin delivery to balloon angioplasty sites in an in vivo porcine model by using a newly designed angiotherapy catheter that allows for prolonged drug infusion while maintaining distal arterial perfusion. Protocols were designed to assess the safety of intracoronary drug delivery, the effect of infusion time and drug concentration on intramural heparin deposition, the distribution of heparin within the arterial wall, the histologic effects of local heparin delivery, the wash-out of intramurally deposited heparin, and the effect of heparin delivery on early platelet deposition following balloon injury in peripheral and coronary vessels. Local intracoronary delivery of heparin was well tolerated in all animals. Between 0.04 and 0.08% of infused heparin was intramurally deposited at the time of drug delivery, with longer infusion durations and higher concentrations of heparin resulting in greater intramural deposition. Autoradiography demonstrated homogenous distribution of heparin throughout the intima, media, and adventitia, with localization in the nuclei, cytoplasm, and extracellular space. Histologic analysis demonstrated no additional vessel trauma from local drug delivery beyond that seen with conventional angioplasty. Wash-out studies demonstrated a biexponential disappearance of intramurally deposited drug, with rapid release of heparin over the first 60 min and persistence of small amounts of drug for at least 7 d. Locally delivered heparin significantly attenuated the deposition of platelets in peripheral vessels, although a similar decrease in platelet deposition in the coronary arteries was not statistically significant. Local delivery of heparin directly to coronary angioplasty sites is possible with the use of a new angiotherapy catheter. Wash-out of heparin from the arterial wall is initially rapid, although drug is detectable for up to 1 wk following delivery. In porcine peripheral arteries, use of this technique significantly decreases early platelet deposition following balloon injury.
本研究的目的是通过使用一种新设计的血管治疗导管,在体内猪模型中评估局部肝素输送至球囊血管成形术部位的疗效,该导管允许长时间药物输注,同时维持远端动脉灌注。设计了相关方案来评估冠状动脉内药物输送的安全性、输注时间和药物浓度对壁内肝素沉积的影响、肝素在动脉壁内的分布、局部肝素输送的组织学效应、壁内沉积肝素的清除情况,以及肝素输送对周围血管和冠状动脉球囊损伤后早期血小板沉积的影响。所有动物对冠状动脉内局部输送肝素的耐受性良好。在药物输送时,0.04%至0.08%的输注肝素壁内沉积,输注持续时间越长和肝素浓度越高,壁内沉积越多。放射自显影显示肝素在整个内膜、中膜和外膜均匀分布,定位于细胞核、细胞质和细胞外空间。组织学分析表明,局部药物输送除了造成与传统血管成形术相同的血管损伤外,未造成额外的血管创伤。清除研究表明,壁内沉积药物呈双指数消失,在最初60分钟内肝素快速释放,少量药物至少持续存在7天。局部输送的肝素显著减轻了周围血管中血小板的沉积,尽管冠状动脉中血小板沉积的类似减少在统计学上不显著。使用新型血管治疗导管可将肝素直接局部输送至冠状动脉血管成形术部位。肝素从动脉壁的清除最初很快,尽管在输送后长达1周仍可检测到药物。在猪的周围动脉中,使用该技术可显著减少球囊损伤后早期血小板的沉积。